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The ovarian follicle is the structural and functional unit of the ovary, composed of the female gamete (the oocyte)
and supportive somatic cells. Follicles are not only the source of a female’s germ cell supply, but also secrete
important hormones necessary for proper endocrine function. Folliculogenesis, the growth and maturation of the
follicular unit, is a complex process governed by both intrafollicular crosstalk and pituitary-secreted hormones. While
the later stages of this process are gonadotropin-dependent, early folliculogenesis appears to be controlled by the
ovarian microenvironment and intrafollicular paracrine and autocrine signaling. In vitro follicle culture remains
challenging because of the limited knowledge of growth factors and other cytokines influencing early follicle
growth. Here we discuss the current state of knowledge on paracrine and autocrine signaling influencing primary
follicles as they develop into the antral stage. Given the importance of intrafollicular signaling and the ovarian
microenvironment, we reviewed the current engineering approaches for in vitro follicle culture, including 3D
systems using natural hydrogels such as alginate and synthetic hydrogels such as poly(ethylene glycol). Our
discussion is focused on what drives the proliferation of granulosa cells, development of the thecal layer, and
antrum formation—three processes integral to follicle growth up to the antral stage. Further research in this area
may reveal the mechanisms behind these complex signaling relationships within the follicle, leading to more
successful and physiologically-relevant in vitro culture methods that will translate well to clinical applications.
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Ovarian folliculogenesis encompasses a wide breadth of
cellular processes beginning in the dormant, primordial
follicle and culminating in a fully mature and develop-
mentally competent oocyte that is ovulated and becomes
available for fertilization. This highly ordered process is
influenced by a milieu of factors from various physiological
domains, particularly the hypothalamic-pituitary-gonadal
(HPG) axis. The HPG axis governs the secretion of hor-
mones that cause cyclical changes in the reproductive
organs. The secreted hormones, beginning with
gonadotropin-releasing hormone (GnRH) from the
hypothalamus, as well as downstream hormones
follicle-stimulating hormone (FSH), luteinizing hor-
mone (LH), estrogen, progesterone, and others, be-
come particularly important during the preovulatory
stage of folliculogenesis, after the follicle’s antrum has* Correspondence: shikanov@umich.edu
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stages of folliculogenesis can proceed independent of
gonadotropins and are instead dependent on intrafol-
licular signaling between the oocyte and the somatic
cells present. New studies continue to emerge reveal-
ing the importance of extracellular signaling factors
within the follicle microenvironment and elucidating
the mechanisms by which intra- and inter-follicular
cytokines initiate and sustain complex paracrine and
autocrine signaling relationships that govern the vari-
ous processes of folliculogenesis until gonadotropins
gain predominate influence. The complexity of intra-
follicular crosstalk can be attributed in part to the
follicle’s 3D architecture and the juxtaposition of the
cells within the follicle. As the follicle expands
throughout folliculogenesis, the somatic cells acquire
distinct phenotypic characteristics due to the gradient
that develops via diffusion of systemic factors into the
follicle and oocyte-derived factors outward from the
oocyte. The importance of these gradients inle is distributed under the terms of the Creative Commons Attribution 4.0
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have been previously studied and there are perhaps
many other processes influenced by these intrafollicu-
lar gradients that have yet to be uncovered [1].
The first stage of folliculogenesis begins when the
primordial follicle, composed of an oocyte and single
layer of pre-granulosa cells, is activated [2]. This process
is not well understood but oocyte-specific transcription
factors such as newborn ovary homeobox (NOBOX),
spermatogenesis and oogenesis helix-loop-helix 1
(SOHLH1), and spermatogenesis and oogenesis
helix-loop-helix 2 (SOHLH2) are believed to be critical
to this initial step [2–5]. At this point, the oocyte is
arrested in the diplotene stage of prophase I of meiosis
and will not regain meiotic competence until just before
ovulation [6]. The follicle transitions into its primary
state as the pre-granulosa cells transform from a squa-
mous to cuboidal morphology and begin to proliferate.
These granulosa cells are surrounded by a layer of extra-
cellular matrix called the basement membrane that acts
as a permeable barrier between the follicle and its envir-
onment. The secondary stage begins as the follicle
acquires multiple layers of granulosa cells and the thecal
layer begins to form outside the basement membrane.
The theca layer will also develop vasculature to provide
nutrients as the follicle expands; however this vascula-
ture does not penetrate the basement membrane and
most soluble factors diffuse in and out, contributing to
the intrafollicular gradient. During this period the oocyte
grows in size but remains in meiotic arrest. However the
cytoplasmic maturation of the oocyte that takes place
during folliculogenesis has been shown to be equally im-
portant to meiotic competency for successful in vitro
maturation, meaning that the oocyte must reach a suffi-
cient diameter and accumulate the nutrients necessary
for early embryonic development [7]. The antrum forms
as a result of both granulosa cell secretions and fluidFig. 1 Schematic detailing the stages of mammalian folliculogenesis taken
Endocrine Reviews, 2009, 30, 6, pp. 624–712 by permission of Oxford Univefrom the thecal vasculature. Before ovulation, a surge of
LH causes the oocyte to mature further, resume meiosis
and progress to metaphase II [8]. The granulosa cells
transition again into cumulus cells and respond to the
LH surge by secreting hyaluronic acid in a process called
cumulus expansion [8]. Following ovulation, the
remaining granulosa and theca cells form the corpus
luteum, which secretes progesterone and inhibin—key
hormones to sustain the earliest stages of pregnancy.
This structure degenerates in a matter of days if preg-
nancy does not result, and the cycle initiates again. Folli-
cles are normally classified with names based on
functional stage but can also be categoriezed according
to the Pedersen and Peters system [9]. This process,
along with common follicle classifications, is visually
depicted in Fig. 1, taken from Edson, Nagaraja, and Mat-
zuk (2009).
The importance of crosstalk between the oocyte
and its surrounding somatic cells has long been rec-
ognized and was first characterized by Gregory Pincus
and E.V. Enzmann in 1935. Their study involved the
isolation of mature oocytes from the follicular struc-
ture, upon which they observed spontaneous resump-
tion of meiosis, leading them to conclude that the
cells surrounding the oocyte somehow held it in mei-
otic arrest [10]. This observation has inspired numer-
ous researchers since, who have identified some of
the particular mechanisms by which the follicular
structure regulates its own growth and maturation.
Later studies revealed how the follicle’s somatic cells
temporally promote oocyte maturation via various
paracrine signals and even more recently, multiple
research groups have identified and characterized nu-
merous factors secreted by the oocyte that influence
granulosa and theca cell processes [8, 11–13] . The
characterization of these signaling pathways is open-
ing doors for researchers in diverse areas offrom Edson et al., “The mammalian ovary from genesis to revelation,”
rsity Press [2]
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applied in the laboratory and in the clinic.
Here we will discuss the state of knowledge in para-
crine signaling governing the primary-to-antral follicle
transition, specifically in murine models that are often
used in the laboratory setting. Studies using other animal
species, such as bovine and ovine models were reviewed
elsewhere [8, 14–17]. The primary-to-antral period of
growth, characterized by the proliferation of granulosa
cells, formation of the thecal layer, and antrum forma-
tion, among other processes, is of especial interest to sci-
entists and engineers designing in vitro follicle culture
systems to promote folliculogenesis and obtain
fertilizable eggs. While progress has been made and
promising new culture techniques are emerging, feasible
and reproducible culture methods to grow and mature
early stage follicles in a dish are still difficult to attain.
Researchers have also struggled to leverage the ample
supply of primordial follicles in the ovary, as some of the
particular mechanisms of early stage folliculogenesis
have yet to be uncovered. We will conclude our discus-
sion by highlighting some of the most recent models im-
plemented for in vitro follicle culture that maintain the
follicle’s 3D architecture and how these methods can be
applied to the growing body of knowledge on
folliculogenesis.
Granulosa cell proliferation
During the late primary stage of folliculogenesis, a
phenotypic change occurs in granulosa cells and they
become proliferative, forming multiple layers around the
oocyte. Many cell-secreted factors have been found to
influence this process, predominately oocyte-secreted
factors: bone morphogenetic protein 15 (BMP-15) and
growth differentiation factor-9 (GDF-9) [18, 19]. The
influence of BMP-15 on granulosa cell proliferation is
particularly interesting and has been well-characterized
by various research groups [13, 20–24]. These studies
suggest a feedback loop between the granulosa cells and
the oocyte involving BMP-15 from the oocyte, kit ligand
from the granulosa cells, and c-Kit (the kit ligand recep-
tor), which is expressed in the oocyte but not in granu-
losa cells. This hypothesized loop is initiated when
BMP-15 from the oocyte stimulates the expression of kit
ligand in granulosa cells, which binds the c-Kit surface
receptor on the oocyte [9]. Kit ligand has been shown to
promote oocyte growth and cytoplasmic maturation,
though the specific mechanisms by which these changes
occur have yet to be uncovered [25–27]. When binding
c-Kit, the ligand also inhibits further BMP-15 expres-
sion, slowing BMP-15-induced proliferation in the gran-
ulosa cells [20]. Once binding bone morphogenetic
protein receptor type-1B (BMPRIB/ALK-6) or bone
morphogenetic protein receptor II (BMPRII), BMP-15initiates kit ligand expression in the granulosa cells via
activation of the Smad1/5/8 pathway [23]. An illustration
of this relationship can be seen in Fig. 2a. BMP-15
appears to be able to induce proliferation independent
of FSH activity, indicating its importance in the stages of
folliculogenesis preceding gonadotropin dependence
[13]. BMP-15 has also been shown to inhibit
FSH-induced cytodifferentiation (among other effects) in
granulosa cells by inhibiting FSH receptor expression
[28]. Together, these findings suggest that BMP-15
impacts both granulosa cell proliferation and
FSH-dependent cytodifferentiation, two mechanisms by
which the oocyte may direct early follicle growth [28].
GDF-9 has been shown to be necessary for granulosa
cell proliferation beyond the primary follicular stage
[29–33]. Unlike BMP-15, GDF-9 causes transcriptional
changes by binding the transforming growth factor-β
receptor 1 (TGFβR1/ALK-5) or BMPRII receptors, caus-
ing activation of Smad2/3 on the target cell surface [34].
One study found that this factor induces expression of
hyaluronan synthase 2 (HAS2), cyclooxygenase 2
(COX-2), and steroidogenic acute regulator protein
(StAR) mRNA in granulosa cells, all of which are key
enzymes involved in proliferation [35]. Much like
BMP-15, GDF-9 has been implicated to participate in a
feedback loop between granulosa cells and the oocyte:
kit ligand from the granulosa cells stimulates oocyte
growth until a certain threshold is reached, at which
point GDF-9 from the oocyte suppresses further kit
ligand expression in the granulosa cells, as seen in
Fig. 2b [8]. Supporting this hypothesis, one study
used Gdf9-null mice to show increased expression of
the Kitl gene in granulosa cells [36]. Taken together,
these pathways may be mechanisms by which the
oocyte can initiate, modulate, and terminate follicle
growth and maturation [13, 28].
Other cytokines have been shown to modulate granu-
losa cell proliferation, however the mechanisms behind
their impact are not yet characterized. Fibroblast growth
factor-8 (FGF-8) has been found to be expressed
throughout the follicle in bovine models and specifically
in the oocyte in rats [37, 38]. Given its similarity to other
members of the fibroblast growth factor family that
stimulate granulosa cell proliferation, and one study in
which transgenic mice with overexpression of FGF-8
showed ovarian stromal cell hyperplasia, future studies
may show this factor to play a role in granulosa cell pro-
liferation [18, 39]. Fibroblast growth factor-2 (FGF-2) or
basic fibroblast growth factor (bFGF), secreted by both
the oocyte and granulosa cells, has been shown to con-
tribute to granulosa cell proliferation in both bovine and
hamster models, and also prevents granulosa cell apop-
tosis in rats via control over intracellular calcium levels
[18, 40–44]. This is not surprising given the proliferative
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ther studies will be necessary to elucidate the mechan-
ism behind FGF-2’s effect on granulosa cells and its
concentration in the follicle microenvironment in vivo
[18]. Bone morphogenetic protein-6 (BMP-6), secreted
by the oocyte, was long suspected to play a role in gran-
ulosa cell proliferation due to its upregulation starting at
the secondary stage of growth, however this factor does
not appear to impact this process [28]. Bone morpho-
genetic protein-7 (BMP-7), expressed by theca cells, also
promotes granulosa cell mitosis, as shown by one study
reporting enhanced granulosa cell DNA synthesis and
proliferation following BMP-7 treatment in vitro [45].
Theca cells also secrete bone morphogenetic protein-2
(BMP-2), which has been shown to influence granulosa
cell proliferation in bovine models but have not been
explored in murine models [13, 29]. Various signaling
pathways initiated by multiple cytokines have also been
shown to be necessary for proper granulosa cell prolifer-
ation, including the Hedgehog signaling pathway, the
Notch signaling pathway, the canonical Wnt/β-catenin
pathway via R-spondin2 (RSPO2) expression, and pos-
sibly the Hippo signaling pathway, although there are
conflicting conclusions drawn from studies in this last
area [46–54].
Granulosa cell proliferation also depends on autocrine
signaling. Granulosa cells secrete activin, bone morpho-
genetic protein-5 (BMP-5), and BMP-2 to promote pro-
liferation [29]. They also secrete epidermal growth factor
(EGF) and FGF-8 that lead to increased kit ligand
expression, promoting not only their own proliferation
but also theca cell proliferation [17, 27, 55]. Migration
inhibitory factor (MIF) is expressed by both the granu-
losa cells and local macrophages and may also influence
this process, given that one study showed that anti-MIF
antibody inhibited granulosa and theca cell proliferation
[17, 56]. Activin A may be another potential factor, as it
has been shown to increase granulosa cell proliferation
when administered exogenously and has been shown to
be present in the preantral follicle microenvironment
[57–60]. Interestingly, activin may also have a role in the
follicle’s transition from dependence on paracrine/auto-
crine signals to gonadotropins, as indicated by one study
in which activin upregulated FSH receptor expression in
undifferentiated granulosa cells [61–63]. Anti-Mullerian
hormone (AMH) is also secreted by the granulosa cell
population and may play a role in proliferation. This
molecule is secreted by the pre-granulosa cells of acti-
vated primordial follicles and is more commonly recog-
nized for its potential role in limiting the pool of
recruited follicles during each ovulation cycle [64]. How-
ever, one study using rat granulosa cells cultured in vitro
found that exogenous AMH caused reduction of aroma-
tase and LH receptor expression, and thereforedampened the proliferative effects of FSH [65, 66].
Transforming growth factor- β (TGF-β) may also play a
role in granulosa cell proliferation and is secreted by all
three major follicular cell types (the oocyte, granulosa
cells, and theca cells), however the results of various
studies on TGF-β have been inconclusive and have var-
ied across species [17, 29]. One study in rats indicate
that theca-secreted TGF-β1 may increase granulosa cell
production of connective tissue growth factor (CTGF),
which may in turn influence the angiogenesis and matrix
remodeling necessary for antrum formation, which will
be discussed in detail later [67].
It should also be noted that many of these secreted
factors play equally important roles in regulating
steroidogenesis in the later stages of folliculogenesis, as
discussed in previous reviews [8, 13]. In addition to fur-
ther studies using transgenic rodents and in vitro cul-
ture, gene expression analysis and transcriptome studies,
such as a recent study characterizing transcriptional
regulation between the oocyte and granulosa cells, must
also be performed to fully understand this and other fol-
licular processes [68].
Theca layer development
As the follicle progresses towards a gonadotropin-
dependent state, the theca layer begins to form. This layer
is comprised of cells largely believed to be recruited from
the ovarian stroma, possibly of a fibroblast-like origin [69].
This recruitment is most likely mediated by an oocyte- or
granulosa cell-secreted factor, however this factor or
group of factors have not been identified or characterized
[27, 70]. The theca layer of cells not only provides struc-
tural support for the follicle but secretes signals relevant
to oocyte-granulosa cell crosstalk and produces key go-
nadotropins in later stages of folliculogenesis. These cells
also become a major constituent of the corpus luteum
after ovulation, where they continue to serve their sex
hormone-producing purposes [70]. Two distinct popula-
tions of theca cells emerge as the secondary stage of folli-
culogenesis begins: a theca externa, expressing bone
morphogenetic protein-4 (BMP-4), and a theca interna
expressing BMP-7 [71]. The theca interna becomes highly
vascularized as folliculogenesis progresses, while the theca
externa is composed of a protective fibrous tissue [72].
Many of the oocyte- and granulosa cell-secreted
factors previously discussed also regulate development
of the theca layer. Kit ligand from granulosa cells,
secreted in part due to oocyte-secreted GDF-9 and
BMP-15, leads to theca cell proliferation via the Erk1/2
pathway [21, 27, 55]. One study using rat theca cells
showed increased differentiation and androsterone pro-
duction when cells were treated with kit ligand and
insulin-like growth factor 1 (IGF-1), another granulosa
cell-secreted factor [73]. GDF-9 also plays a key role in
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one study using a GDF-9 deficient mouse model [36].
Important thecal markers were not detectable and a dis-
tinct layer could not be observed using light or electron
microscopy, indicating that without GDF-9, the follicle
was unable to recruit thecal precursor cells [36].
Whether GDF-9 affects the thecal layer directly or indir-
ectly is unknown, however this study suggests some
secreted thecal precursor recruitment factor is modu-
lated by GDF-9 expression, indicating an indirect influ-
ence [36]. Granulosa cell- and macrophage-secreted MIF
may also influence thecal development, as previously de-
scribed [56]. Fibroblast growth factor-7 (FGF-7) may
also contribute to early recruitment and development of
the thecal layer, as indicated by one study in which the
factor was found localized in thecal precursor cells [74].
This research group hypothesized that FGF-7 production
in these cells was stimulated by kit ligand from the gran-
ulosa cell population and created a positive feedback
loop in which FGF-7 upregulates kit ligand production
[74]. Granulosa cell-derived EGF and FGF-8 also upreg-
ulate theca layer development, as previously mentioned.
As the theca layer develops, angiogenesis occurs such
that new capillaries become integrated into the layer.
This process can be modulated by granulosa cell-
secreted FGF-2 and circulating leptin, platelet-derived
growth factor subunit B (PDGFB), and vascular endothe-
lial growth factor (VEGF) already present in the follicle
[17, 18, 72, 75, 76]. VEGF expression in the granulosa
and theca cells increases as folliculogenesis continues
and contributes to the increasing vascularization and
oxygenation of the follicle [77]. VEGF expression in
these cell types can be mediated by interleukin 6 (IL-6),
FSH, and human chorionic gonadotropin (hCG) [77].
Antrum formation
The formation of the fluid-filled antrum cavity marks an
important transition in follicle development. During pre-
antral growth, multiple pockets of fluid form throughout
the follicle and then coalesce into one large cavity [78].
As the antrum forms, the granulosa cells are divided into
two populations: the cumulus granulosa cells proximal
to the oocyte and the mural granulosa cells lining the
inside of the follicular wall [79]. The follicular fluid in
this cavity is composed largely of components from the
blood that diffuse out of the thecal capillaries, as well as
secretions from the granulosa cells like hyaluronan [78].
Researchers hypothesize that this process largely de-
pends on the development of an osmotic gradient that
draws fluid into the follicle from the thecal vasculature.
Aquaporins, transmembrane proteins that serve as water
channels, are expressed by the granulosa cells and may
help to facilitate this process via the influx of fluid from
the theca layer’s vasculature that coalesces into theantral structure [53, 80]. Granulosa cell secretions of
hyaluronan, a glycosaminoglycan largely found in extra-
cellular matrix throughout the body’s tissues, and versi-
can, an extracellular matrix proteoglycan, are believed to
contribute to this process, as previously mentioned [78].
Versican may also bind hyaluronan molecules in order
to keep them within the antrum [78].
Antrum formation is predominantly influenced by
FSH secreted by the pituitary, however some para-
crine signals have been shown to exert indirect influ-
ence over this process [27]. In one study, preantral
follicles were stimulated with activin A and showed
increased formation of antrum-like structures [57]. In
fact, in this study antrum formation did not occur
without the addition of activin A to the culture
medium, even when FSH was present [57]. Like the
other processes discussed thus far, kit ligand from the
granulosa cells is necessary for antrum formation as
the follicle progresses towards ovulation, perhaps
partly due to its ability to stimulate somatic cell pro-
liferation and other related processes that affect an-
trum formation downstream [21, 26, 78, 81, 82]. In
one study, the monoclonal anti-c-kit antibody ACK2,
which blocks kit-kit ligand binding, was injected
in vivo and suppressed antrum formation [83]. Nu-
merous factors have been shown to influence the se-
cretion of versican by the granulosa cells, including
LH and hCG, as well as exogenous forskolin, an ad-
enylate cyclase stimulator that increases intracellular
cAMP [46]. This study also found versican to be
expressed in primary follicles (before FSH influences
growth), suggesting that its expression at this early
stage might be mediated by a member of the TGFβ
family like activin or GDF-9 [46].
Many other oocyte- and somatic cell-secreted factors
may influence antrum formation but have yet to be iden-
tified. Because angiogenesis plays a large role in the for-
mation of the thecal vasculature, and antrum formation
in turn depends on the diffusion of fluid out of the the-
cal capillaries, angiogenic factors like VEGF and leptin
may indirectly influence antrum formation [78]. Simi-
larly, in order for the antrum to form, major extracellu-
lar matrix remodeling must occur. As previously
mentioned, TGF-β1 from theca cells may mediate granu-
losa cell production of CTGF, a factor known to mediate
angiogenic processes and extracellular matrix remodel-
ing [67, 84]. This discussion brings to light the deeply
complex signaling relationships governing the
gonadotropin-independent stages of folliculogenesis.
Table 1 highlights some of the factors discussed that are
most well-characterized in murine models. Much is still
unknown about how these factors interact and facilitate
various processes within the follicular structure. Without
this knowledge, researchers lack some of the tools
Table 1 Follicle-secreted factors and their functions, classified
by secreting cell type
Oocyte-Secreted Factors
BMP-15, GDF-9 Promotes granulosa proliferation and theca layer
development [13, 20–24, 27, 35, 55]





Promote granulosa cell proliferation [29, 57–60]
MIF, EGF, FGF-8 Promote theca layer development [17, 27, 55, 56]
FGF-2 Promote theca layer angiogenesis [18, 76]
Aquaporin,
Versican
Facilitate antrum development [53, 78, 80]
Theca Cell-Secreted Factors
BMP-7 Promotes granulosa cell proliferation [45]
FGF-7 Promotes theca layer development [74]
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in vitro follicle culture and for clinical applications re-
lated to various reproductive disorders.
Existing bioengineering approaches to direct
Folliculogenesis
In order to elucidate the unknown mechanisms of follicu-
logenesis and translate this new knowledge into clinical
applications, physiologically-relevant and reproducible
in vitro culture systems must be developed for the labora-
tory setting. John Eppig was the first to culture follicles
in vitro in 1977, using a 2D method involving enzymatic
digestion of ovarian tissue to collect follicles, followed by
culture in 24-well plastic culture dishes [85]. His studies
indicated that oocytes can be grown in vitro but require
physical contact with their somatic cells [85]. A more
recent study from J. Eppig’s group investigating the tran-
scriptional activity in follicles at different developmental
stages indicated that as the follicle grows, its 3D structure
leads to gradients of nutrients, oxygen, oocyte-derived and
systemic factors between the layers of granulosa cells in a
follicle. Granulosa cells proximal to the oocyte receive
more oocyte-derived factors than those further away, and
those further away receive higher concentrations of sys-
temic hormones and paracrine factors [1]. These gradients
were shown via gene expression analysis to impact cell dif-
ferentiation and follicle growth and maturation [1]. Given
the importance of maintaining the follicle’s complex archi-
tecture, 3D culture methods have become the standard
for researchers in this field. A comparison of 2D and 3D
culture methods in the context of maintaining intrafollicu-
lar signaling gradients can be seen in Fig. 3. Numerous
engineering approaches have been employed to meet the
mechanical needs of ovarian follicles, however encapsulat-
ing follicles in natural or synthetic hydrogels is the mostwidely used. These microenvironments must meet several
design criteria, as previously outlined by Shea, Woodruff,
and Shikanov [86]. These include gentle culture condi-
tions, maintenance of cell-cell connectivity, adequate dif-
fusivity for nutrients from culture medium, an allowance
for significant follicle expansion, and ease of retrieval upon
experiment completion [86].
With regards to providing mechanical stability, algin-
ate was the first biomaterial to be implemented for fol-
licle culture. This polysaccharide is derived from algae
and has a mild gelation process ideal for use with folli-
cles [86]. The hydrogel can be modified by immobilizing
extracellular matrix proteins or peptides in the gel that
will allow the follicle to interact with its microenviron-
ment and can be easily dissolved using alginate lyase.
One of the first studies to use alginate for follicle culture
reported both oocyte growth and granulosa cell prolifer-
ation in these encapsulated follicles [87]. Since this ini-
tial study, various research groups have optimized their
own methods for follicle culture using alginate and these
3D systems have led to numerous discoveries regarding
folliculogenesis. Researchers generally use alginate at
lower concentrations, as concentration has been found
to be inversely proportional to the follicle’s capacity for
antrum formation and maturation [88–91]. Alginate is
non-susceptible to mammalian enzyme degradation and
subjects encapsulated follicles to constant or increasing
compressive forces during culture. Incorporation of fi-
brin into alginate hydrogels allows cellular proteases to
degrade the matrix over time and creates a dynamic
mechanical environment. One of the early studies using
this hydrogel system reported the successful culture of
secondary follicles, resulting in an 82% recovery rate of
meiotically competent oocytes at the end of culture [92].
Fibrin-alginate was used in later studies by two research
groups to study in vitro maturation of baboon oocytes
and in vitro culture of primary and secondary rhesus
macaque follicles, respectively [93, 94]. These nonhuman
primate studies are important steps towards culture of
human follicles in vitro, however naturally-derived
matrices come with inherent heterogeneity that may not
translate well into clinical applications. Poly(ethylene--
glycol) (PEG) has also emerged as a popular hydrogel for
follicle culture. This synthetic polymer can be modified
with functional groups that result in varied gelation
times and mechanical properties [95, 96]. Like many of
its naturally-derived counterparts, PEG can be modified
with peptides that will allow the follicle to degrade the
matrix as it grows [91]. PEG may emerge as a superior
hydrogel for in vitro follicle culture as scientists and en-
gineers look towards clinical implementation of their
methods.
Other research teams have focused on optimizing
in vitro culture conditions to recapitulate the complex
AB
Fig. 2 a) Oocyte-secreted BMP-15 promotes mitosis and kit ligand expression in granulosa cells and b) granulosa cell-secreted kit ligand
promotes oocyte growth but is suppressed by oocyte-secreted GDF-9
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have often been employed to provide these secreted fac-
tors, as shown in Fig. 4 [91]. Common cell types used in
these models include ovarian mesenchymal cells, murine
embryonic fibroblasts (MEFs), stromal cells, and granu-
losa cells [97–100]. One study tested five different cul-
tures systems to elucidate the most successful co-culture
conditions for in vitro follicle culture: monoculture in
minimum essential medium and in coconut water, as
well as co-cultures with ovarian mesenchymal cells,
granulosa cells, or cumulus cells [97]. Both monoculture
conditions showed little success, however the co-cultureconditions showed significantly increased growth rates
and oocyte retrieval rate, with co-culture with cumulus
cells or mesenchymal cells being most successful [97]. In
another study, preantral follicles were cultured with
MEFs and researchers observed increased survival (90%
vs. 77% in the control group) and significantly larger fol-
licle diameters after 6 and 8 days of culture [98]. In a
similar study using MEFs and primary follicles encapsu-
lated in alginate hydrogels, follicles showed increased
survival and the majority of oocytes successfully pro-
gressed to metaphase II [99]. In this study,
fibroblast-conditioned media had similar effects to actual
A B
C
Fig. 3 Growth factors and nutrients are more capable of promoting follicle growth when the structure is cultured in 3D (b) versus in 2D culture
(a), especially given the complex crosstalk between cells within the follicle (c)
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importance of somatic cell-secreted factors for proper
follicle growth [99]. One research group used alginate to
encapsulate their co-culture of follicles with ovarian
stromal cells, mostly comprised of macrophages and the-
cal cells [100]. They successfully cultured both late pri-
mary and small secondary follicles in their co-cultureFig. 4 a) Co-culture with feeder cells can provide follicles with secreted fac
also enhance growth and development via interfollicular crosstalksystem and used their results to infer the importance of
various secreted factors during early stage folliculogen-
esis [100].
Multiple follicle culture has also proven an effective
method for in vitro culture. Given the improvements to
early follicle culture seen using co-culture systems with
the cell types discussed previously, it has become cleartors in order to enhance growth and b) multiple follicle culture can
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vide all the nutrients necessary for early folliculogenesis,
but some of the factors secreted by other cell types en-
hance growth. Multiple follicle culture seeks to provide
a microenvironment with an amplified supply of
follicle-secreted factors that may be necessary for early
folliculogenesis via interfollicular crosstalk, as shown in
Fig. 4 [101]. Co-culture with other cell types is not a sus-
tainable in vitro culture method, given foreseeable diffi-
culties in identifying media components that can satisfy
both cell types; multiple follicle culture, however, may
indicate what factors are secreted by follicles and are
present in the follicle microenvironment, allowing
researchers to leverage this information to modify the
supplements used for individual follicle culture. In the
first study using this method, follicles were encapsulated
in alginate in groups of five and ten [101]. Primary folli-
cles cultured in groups showed enhanced growth and
survival, the largest number of follicles together (n = 10)
yielding the best results [101]. This study provided new
insight into the importance of the follicular unit and has
prompted other research groups to further probe the
mechanisms by which multiple follicle culture enhances
growth and development. However, multiple follicle cul-
ture may not translate well into clinical applications,
given the need to encapsulate follicles of homogeneous
size and growth stage and the importance of dominant
follicle emergence in human folliculogenesis. One study
recently sought to expose how paracrine signaling within
the follicle might vary between follicles cultured indi-
vidually or in groups as previously described [102].
Using Transcriptional Activity CEllular aRray (TRACER)
technology, they uncovered unique transcription factor
expression signatures in follicles cultured in groups of
ten versus in groups of five or individually [102]. NF-κB
(nuclear factor kappa-light-chain-enhancer of activated
B cells), HIF1 (hypoxia-inducible factor-1), and VEGF-A
were among the factors with significantly upregulated
expression [102]. Continued studies like this may reveal
the interactions of cytokines and transcription factors
during different stages of folliculogenesis, aiding in our
understanding of how crosstalk within the follicle im-
pacts growth and maturation. Future research in this
area will work towards the development of a culture
medium that includes all the factors necessary for follicle
growth at each stage of development [86]. The applica-
tions of this new technology would be endless, ranging
from discoveries in basic science to development of clin-
ical treatments for various forms ovarian disorders.
Conclusions
Folliculogenesis is clearly a highly ordered process with
a variety of factors being expressed to varying degrees
throughout follicle development. Here we have discussedsecreted factors pertinent to the primary to antral stages
of follicle growth, given the need to enhance in vitro cul-
ture methods for early stage follicles. Oocyte- and som-
atic cell-secreted factors play important roles in early
follicle development and may also impact how gonado-
tropins affect the follicle during later stages of folliculo-
genesis. Many signaling relationships between the oocyte
and granulosa cells, and granulosa and theca cells, have
already been characterized, and there are potentially
many more to be uncovered. The oocyte has already
been shown to hold immense influence over follicle
growth and maturation, given the importance of its
secretions of BMP-15 and GDF-9. Granulosa and theca
cells also appear to perform specific secretory functions
throughout folliculogenesis, regulating somatic cell
growth and influencing oocyte maturation. Studies on
transcriptional changes and gene expression such as
those performed by Zhou et al. (2018) and Biase et al.
(2018) will also contribute to a more complete picture of
crosstalk within the follicle [68, 102]. To clarify these in-
tricate relationships, physiologically-relevant and highly
controllable in vitro systems must be implemented, such
as the specially-engineered PEG hydrogels previously
discussed. Development and application of these models,
coupled with the design of a culture medium including
all the key secreted factors necessary for growth at dif-
ferent stages, could be applied to individual follicle cul-
ture to access the large primordial follicle pool and open
new doors for clinical treatment of various female repro-
ductive disorders.
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